Chemed Corporation (CHE) Financials
CHE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2026 | 1.7 billion | 857.0 million |
| June 30, 2026 | 1.6 billion | 749.1 million |
| March 31, 2026 | 1.5 billion | 687.8 million |
| Dec. 31, 2025 | 1.6 billion | 660.6 million |
CHE Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2026 | 37.9 million | 9.1 million |
| June 30, 2026 | 69.3 million | 9.1 million |
| March 31, 2026 | 71.1 million | 1.4 million |
| Dec. 31, 2025 | 117.2 million | 23.5 million |
CHE Net Income
| Date | Net Income |
|---|---|
| Sept. 30, 2026 | 71.6 million |
| June 30, 2026 | 67.7 million |
| March 31, 2026 | 66.3 million |
| Dec. 31, 2025 | 76.8 million |
CHE Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2026 | 48.4 million | 236.0 million | 156.2 million |
| June 30, 2026 | 40.2 million | 140.0 million | 113.5 million |
| March 31, 2026 | 16.9 million | 91.2 million | 145.7 million |
| Dec. 31, 2025 | 74.5 million | - | 102.9 million |
CHE Shares Outstanding
CHE Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2026 | 18.7 million | - | 111.5 million | - |
| June 30, 2026 | 15.5 million | - | 115.2 million | - |
| March 31, 2026 | 17.1 million | - | 114.3 million | - |
| Dec. 31, 2025 | 16.3 million | - | 105.5 million | - |
CHE Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2026 | 690.9 million | 458.0 million |
| June 30, 2026 | 673.3 million | 468.8 million |
| March 31, 2026 | 657.5 million | 458.6 million |
| Dec. 31, 2025 | 639.3 million | 433.3 million |
CHE Revenue by Segment
CHE
List: Contenders
Price: $548.22
Dividend Yield: 0.11%
Forward Dividend Yield: 0.51%
Payout Ratio: 10.15%
Dividend Per Share: 2.80 USD
Earnings Per Share: 20.88 USD
P/E Ratio: 25.97
Exchange: NYQ
Sector: Healthcare
Industry: Medical Care Facilities
Country: United States
Volume: 83400
Ebitda: 68.2 millionMarket Capitalization: 7.0 billion
Average Dividend Frequency: 4
Years Paying Dividends: 42
DGR3: 13.13%
DGR5: 10.27%
DGR10: 8.95%
DGR20: 12.55%